Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A site-wide notice about NIH terminology updates was added, and the site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:06:29.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier advances from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-07T01:04:51.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the previous full content and navigation with a minimal header. Users can no longer view the study details and related links on this page.
    Difference
    17%
    Check dated 2026-09-23T01:12:57.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0 on the study page, representing a minor update to the record without altering study content. This reflects a backend update to the page rather than a change to participant information.
    Difference
    0.0%
    Check dated 2026-09-16T00:12:05.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.6, reflecting a CMS/software maintenance update rather than a change to study data or visible content.
    Difference
    0.0%
    Check dated 2026-09-01T20:10:17.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A new entry '2017 ( U.S. NIH Grant/Contract )' was added to the Study ID Numbers, recording an additional funding attribution for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T20:03:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.